July 9 (Reuters) - Gilead Sciences Inc GILD.O:
GILEAD SCIENCES: AGREEMENT WITH GLOBAL FUND TO ACCELERATE ACCESS TO LENACAPAVIR FOR HIV PREVENTION IN LOW-INCOME COUNTRIES
GILEAD SCIENCES: TO PROVIDE LENACAPAVIR TO 2 MILLION PEOPLE OVER 3 YEARS IN COUNTRIES SUPPORTED BY GLOBAL FUND, AT NO PROFIT TO GILEAD